Skip to main content
ALIVUS LIFE SCIENCES LIMITED logo

ALIVUS LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · ALIVUS ISIN · INE03Q201024 LEI · 335800RYVA1DKP696G32 BSE.NS Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2022-08-04 Regulatory Filings
Country IN India
Listing BSE.NS ALIVUS

About ALIVUS LIFE SCIENCES LIMITED

https://www.alivus.com

Alivus Life Sciences Limited is a pharmaceutical organization dedicated to the formulation, production, and commercialization of a broad spectrum of healthcare solutions. The company operates across multiple therapeutic categories, including gastroenterology, anti-infectives, pain management, and nutritional supplements. Its product range includes diverse delivery formats such as tablets, capsules, syrups, and injectable medications. Alivus Life Sciences focuses on maintaining rigorous quality control protocols and manufacturing excellence to deliver reliable therapeutic outcomes. The company utilizes a robust distribution infrastructure to supply its pharmaceutical products to healthcare providers and patients, prioritizing the accessibility of essential medicines and the continuous expansion of its therapeutic portfolio.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2022-08-04 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 90% confidence The document is an invitation to a Q1 FY2022-23 earnings call for Glenmark Life Sciences Ltd. It includes details such as date, time, dial-in numbers, and contact information for registration. There is no financial data or analysis presented, only logistical information for a conference call. This matches the characteristics of a Call Transcript (CT) document type, specifically the invitation or announcement for an earnings call. However, since it is only an invitation and not the transcript itself, it is still best classified as a Call Transcript (CT) because it relates directly to the earnings call event. The document length is short and does not contain financial results or management discussion, so it is not an Earnings Release (ER) or Interim Report (IR).
2022-07-27 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document text is extremely short (118 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2022-07-22 English
Board Meeting — Financial results
Regulatory Filings Classification · 90% confidence The document text is extremely short (118 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report title, no regulatory references, or any indication of the document's purpose. Given the lack of content, it cannot be classified as a report or announcement of a report. According to the rules, such minimal content with no meaningful information defaults to Regulatory Filings (RNS) as a fallback category.
2022-07-22 English
Related Party Transaction
Regulatory Filings
2022-05-31 English
Monitoring Agency Report
Regulatory Filings
2022-05-13 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.